Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma

被引：3
|
作者：
Krishnan, Jerry A. [1 ]
Au, David H. [2 ,3 ]
机构：
[1] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, 1220 S Wood St,MC 619, Chicago, IL 60608 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Ctr Innovat Vet Ctr & Value Driven Care, Hlth Serv Res & Dev Serv, Seattle, WA USA
[3] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 14期
关键词：
D O I：
10.1001/jama.2018.2029
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1441 / 1443
页数：3
相关论文
共 44 条
  • [21] The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper
    Semenzato, Umberto
    Previtero, Daniele
    Padrin, Ylenia
    Baraldo, Simonetta
    Tine, Mariaenrica
    ALLERGY, 2025,
  • [22] Effects of Treatment with Long-Acting Muscarinic Antagonists and Long-Acting Beta-Agonists on Lung Function Improvement in Patients with Bronchiectasis: An Observational Study
    Lee, S.
    Lee, J.
    Lee, S.
    Oh, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2 - agonists (LABA) for adults with asthma
    Kew, Kayleigh M.
    Evans, David J. W.
    Allison, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [24] The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma.
    Chowdhury, Badrul A.
    Dal Pan, Gerald
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (13): : 1169 - 1171
  • [25] Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma
    Krishnan, Jerry A.
    Lazarus, Stephen C.
    Blake, Kathryn, V
    Sorkness, Christine A.
    Covar, Ronina
    Dyer, Anne-Marie
    Lang, Jason E.
    Lugogo, Njira L.
    Mauger, David T.
    Wechsler, Michael E.
    Wenzel, Sally E.
    Cardet, Juan Carlos
    Castro, Mario
    Israel, Elliot
    Phipatanakul, Wanda
    King, Tonya S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (03) : 372 - 380
  • [26] Asthma Guidelines Priority Topic: Long-Acting Anti-Muscarinic Agents in Asthma Management as Add-On to Inhaled Corticosteroids
    Blake, Kathryn V.
    Raissy, Hengameh H.
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2018, 31 (03) : 199 - 203
  • [27] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [28] Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study
    Lee, Su Yeon
    Lee, Jae Seung
    Lee, Sei Won
    Oh, Yeon-Mok
    JOURNAL OF THORACIC DISEASE, 2021, 13 (01) : 169 - U89
  • [29] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
    Evans, David J. W.
    Kew, Kayleigh M.
    Anderson, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):
  • [30] Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma A Systematic Review and Meta-analysis
    Sobieraj, Diana M.
    Baker, William L.
    Nguyen, Elaine
    Weeda, Erin R.
    Coleman, Craig I.
    White, C. Michael
    Lazarus, Stephen C.
    Blake, Kathryn V.
    Lang, Jason E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1473 - 1484
12345